Im­pel lever­ages big-time mi­graine cam­paigns from com­peti­tors Ab­b­Vie, Bio­haven for its in­tranasal Trud­he­sa launch

Small phar­ma play­ers can’t match the big-time ad­ver­tis­ing spend­ing of Big Phar­ma. But they can lever­age it — and that’s ex­act­ly what Im­pel Phar­ma­ceu­ti­cals is do­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER